tradingkey.logo
tradingkey.logo
검색

Anbio Biotechnology

NNNN
관심 목록에 추가
12.700USD
+0.355+2.88%
종가 07/02, 13:00ET시세는 15분 지연됩니다
557.42M시가총액
86.61P/E TTM

자세한 내용은 Anbio Biotechnology 회사

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology 정보

종목 코드 NNNN
회사 이름Anbio Biotechnology
상장일Feb 19, 2025
CEOLau (Michael)
직원 수27
유형Ordinary Share
회계 연도 종료Feb 19
주소Friedrich-Ebert-Anlage 49
도시FRANKFURT AM MAIN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Germany
우편 번호60308
전화4916096247281
웹사이트https://anbiobiotechnology.com/
종목 코드 NNNN
상장일Feb 19, 2025
CEOLau (Michael)

Anbio Biotechnology의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

자주 묻는 질문

Anbio Biotechnology의 상위 5대 주주는 누구인가요?

Anbio Biotechnology의 상위 5대 주주는 다음과 같습니다: Mr. Michael Lau

Anbio Biotechnology(NNNN)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Anbio Biotechnology의 주식을 보유한 기관은 총 13곳이며, 이들이 보유한 주식의 총 가치는 약 2.13M로 전체 발행 주식의 4.86%를 차지합니다. 이는 2025Q4 대비 2063041.00 증가한 수치입니다.